HARDY et al v. JANSSEN PHARMACEUTICALS, INC. et al

Justia Dockets & Filings Judicial Panel on Multidistrict Litigation HARDY et al v. JANSSEN PHARMACEUTICALS, INC. et al

HARDY et al v. JANSSEN PHARMACEUTICALS, INC. et al

Plaintiff:	HARDY, ROGER HARDY and CAROL HARDY
Defendant:	JANSSEN PHARMACEUTICALS, INC, JANSSEN RESEARCH & DEVELOPMENT LLC, JANSSEN PHARMACEUTICA INC, ORTHO-MCNEIL PHARMACEUTICALS, LLC, JANSSEN ORTHO, LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC, JOHNSON & JOHNSON, ABC CORPORATION 1-20, Janssen Pharmaceuticals Inc., Janssen Research and Developement, LLC, ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC., Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC
Case Number:	NJ/2:20-CV-12608
Filed:	September 11, 2020
Court:	Judicial Panel on Multidistrict Litigation
Presiding Judge:	Brian R Martinotti
Nature of Suit:	Other

RSS Track this Docket

Docket Report

This docket was last retrieved on December 16, 2020. A more recent docket listing may be available from PACER.

Date Filed	Document Text
December 16, 2020	Filing 26 OFFICIAL TRANSCRIPT of Hearing held on 12/3/2020 before the Panel at Washington, DC. Court Reporter/Transcriber Bryan Wayne, 333 Constitution Avenue, N.W., Room 4704-A, Washington, DC 20001, bryan_wayne@dcd.uscourts.gov. Transcript may be viewed at the Panel's office or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Redaction due 12/23/2020. Redaction Request due 1/6/2021. Redacted Transcript Deadline set for 1/16/2021. Release of Transcript Restriction set for 3/16/2021.Signed by Clerk of the Panel John W. Nichols on 12/16/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/3:20-cv-06070, NJ/3:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (RH)
December 15, 2020	Filing 25 TRANSFER ORDER re: pldg. ( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( #1 in MDL No. 2973) Transferring 39 action(s) to Judge Brian R. Martinotti in the New Jersey.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 12/15/2020. Associated Cases: MDL No. 2973 et al. (TF)
November 16, 2020	Filing 24 SUPPLEMENTAL NOTICE OF HEARING SESSION re: pldg. (15 in ALN/2:20-cv-00993, 19 in CAS/3:20-cv-01266, 16 in FLM/2:20-cv-00330, 12 in FLM/5:20-cv-00390, 12 in FLS/0:20-cv-61721, 20 in FLS/1:20-cv-23144, 19 in FLS/1:20-cv-23380, 12 in FLS/1:20-cv-23500, #102 in MDL No. 2973, 21 in MOW/4:20-cv-00543, 21 in MOW/4:20-cv-00544, 12 in NCM/1:20-cv-00718, 12 in NCM/1:20-cv-00769, 16 in NJ/3:20-cv-06070, 15 in NJ/3:20-cv-07079, 17 in NJ/3:20-cv-07750, 17 in NJ/3:20-cv-07753, 17 in NJ/3:20-cv-07756, 16 in NJ/3:20-cv-07758, 16 in NJ/3:20-cv-08074, 16 in NJ/3:20-cv-09530, 21 in NJ/3:20-cv-10080, 23 in NJ/3:20-cv-10341, 23 in NJ/3:20-cv-10342, 21 in NJ/3:20-cv-10960, 21 in NJ/3:20-cv-10966, 21 in NJ/3:20-cv-10968, 21 in NJ/3:20-cv-11440, 21 in NJ/3:20-cv-11912, 21 in NJ/3:20-cv-11913, 21 in NJ/3:20-cv-11919, 21 in NJ/3:20-cv-11921, 21 in NJ/3:20-cv-12264, 15 in NJ/3:20-cv-12328, 17 in NJ/3:20-cv-12421, 16 in NJ/3:20-cv-12605, 16 in NJ/3:20-cv-12608, 6 in OHN/4:20-cv-01984, 12 in OHS/1:20-cv-00675, 10 in PAE/2:20-cv-02147, 10 in PAE/2:20-cv-02150, 10 in PAE/2:20-cv-02183, 10 in PAE/2:20-cv-02207, 9 in PAE/2:20-cv-02234, 10 in PAE/2:20-cv-02871, 10 in PAE/2:20-cv-03056, 9 in PAE/2:20-cv-03345, 10 in PAE/2:20-cv-04021, 9 in PAE/2:20-cv-04024, 14 in PAE/2:20-cv-04053, 13 in PAE/2:20-cv-04133, 13 in PAE/2:20-cv-04153, 8 in PAE/2:20-cv-04157, 8 in PAE/2:20-cv-04158, 9 in PAE/2:20-cv-04160, 8 in PAE/2:20-cv-04162, 13 in PAE/2:20-cv-04179, 8 in PAE/2:20-cv-04389, 9 in PAE/2:20-cv-04394, 8 in PAE/2:20-cv-04397, 8 in PAE/2:20-cv-04423, 9 in PAE/2:20-cv-04488, 13 in WIE/2:20-cv-01256, 13 in WIE/2:20-cv-01309) Signed by Clerk of the Panel John W. Nichols on 11/16/2020. Associated Cases: MDL No. 2973 et al. (dld)
November 9, 2020	Filing 23 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #1 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants Alza Corporation, #et al.Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals, Inc,, Janssen Ortho LLC, Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., JANSSEN PHARMACEUTICALS, INC., BAYER CORPORATION, BAYER US L.L.C., Centocor Research & Development, Inc. #[Suppress List] (Attachments: #1 Other Parties Represented, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert)
November 9, 2020	Filing 22 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #102 in MDL No. 2973, 15 in NJ/3:20-cv-07079, 17 in NJ/3:20-cv-07750, 17 in NJ/3:20-cv-07753, 17 in NJ/3:20-cv-07756, 16 in NJ/3:20-cv-07758, 16 in NJ/3:20-cv-08074, 16 in NJ/3:20-cv-12605, 16 in NJ/3:20-cv-12608) Filed by Hunter J. Shkolnik on behalf of Plaintiffs LYNN BREWER, #et al.WILLIAM BREWER, CARLIE ANTHONY, REBECCA ANTHONY, EDWARD HULL, VALERIE HULL, DEBORAH EDWARDS, BARBARA MAYOU, KEITH MAYOU, DAVID MCCALL, SHERYL MCCALL, HARRIET COMSTOCK, CAROL HARDY, ROGER HARDY #[Suppress List] (Attachments: #1 Schedule of Actions Schedule of Actions) Associated Cases: MDL No. 2973, NJ/3:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-12605, NJ/3:20-cv-12608 (Shkolnik, Hunter)
October 29, 2020	Filing 21 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( #108 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael)
October 28, 2020	Filing 20 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (17 in ALN/2:20-cv-00993, 21 in CAS/3:20-cv-01266, 18 in FLM/2:20-cv-00330, 13 in FLM/5:20-cv-00390, 13 in FLS/0:20-cv-61721, 3 in FLS/0:20-cv-62068, 23 in FLS/1:20-cv-23144, 21 in FLS/1:20-cv-23380, 13 in FLS/1:20-cv-23500, 5 in ILN/1:20-cv-05989, #108 in MDL No. 2973, 23 in MOW/4:20-cv-00543, 23 in MOW/4:20-cv-00544, 13 in NCM/1:20-cv-00718, 13 in NCM/1:20-cv-00769, 17 in NJ/2:20-cv-07079, 18 in NJ/3:20-cv-06070, 19 in NJ/3:20-cv-07750, 19 in NJ/3:20-cv-07753, 19 in NJ/3:20-cv-07756, 18 in NJ/3:20-cv-07758, 18 in NJ/3:20-cv-08074, 18 in NJ/3:20-cv-09530, 23 in NJ/3:20-cv-10080, 25 in NJ/3:20-cv-10341, 25 in NJ/3:20-cv-10342, 23 in NJ/3:20-cv-10960, 23 in NJ/3:20-cv-10966, 23 in NJ/3:20-cv-10968, 23 in NJ/3:20-cv-11440, 23 in NJ/3:20-cv-11912, 23 in NJ/3:20-cv-11913, 23 in NJ/3:20-cv-11919, 23 in NJ/3:20-cv-11921, 23 in NJ/3:20-cv-12264, 17 in NJ/3:20-cv-12328, 18 in NJ/3:20-cv-12421, 7 in NJ/3:20-cv-12547, 18 in NJ/3:20-cv-12605, 18 in NJ/3:20-cv-12608, 10 in NJ/3:20-cv-13596, 7 in NJ/3:20-cv-13940, 5 in NJ/3:20-cv-14439, 3 in NJ/3:20-cv-14447, 3 in NJ/3:20-cv-14448, 3 in NJ/3:20-cv-14450, 3 in NJ/3:20-cv-14452, 3 in NJ/3:20-cv-14663, 3 in NJ/3:20-cv-14668, 3 in NJ/3:20-cv-14670, 7 in OHN/4:20-cv-01984, 13 in OHS/1:20-cv-00675, 4 in OHS/1:20-cv-00755, 11 in PAE/2:20-cv-02147, 11 in PAE/2:20-cv-02150, 11 in PAE/2:20-cv-02183, 11 in PAE/2:20-cv-02207, 10 in PAE/2:20-cv-02234, 11 in PAE/2:20-cv-02871, 11 in PAE/2:20-cv-03056, 10 in PAE/2:20-cv-03345, 11 in PAE/2:20-cv-04021, 10 in PAE/2:20-cv-04024, 15 in PAE/2:20-cv-04053, 14 in PAE/2:20-cv-04133, 14 in PAE/2:20-cv-04153, 9 in PAE/2:20-cv-04157, 9 in PAE/2:20-cv-04158, 10 in PAE/2:20-cv-04160, 9 in PAE/2:20-cv-04162, 14 in PAE/2:20-cv-04179, 9 in PAE/2:20-cv-04389, 10 in PAE/2:20-cv-04394, 9 in PAE/2:20-cv-04397, 9 in PAE/2:20-cv-04423, 10 in PAE/2:20-cv-04488, 7 in PAE/2:20-cv-04726, 4 in PAE/2:20-cv-04773, 4 in PAE/2:20-cv-04775, 4 in PAE/2:20-cv-04777, 4 in PAE/2:20-cv-04778, 4 in PAE/2:20-cv-04779, 4 in PAE/2:20-cv-04787, 4 in PAE/2:20-cv-04788, 4 in PAE/2:20-cv-04789, 4 in PAE/2:20-cv-04790, 4 in PAE/2:20-cv-04791, 4 in PAE/2:20-cv-04929, 3 in PAE/2:20-cv-04936, 3 in PAE/2:20-cv-04945, 14 in WIE/2:20-cv-01256, 14 in WIE/2:20-cv-01309) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael)
October 23, 2020	Filing 19 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( #1 in MDL No. 2973) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 10/23/2020. Associated Cases: MDL No. 2973 et al. (TF)
October 22, 2020	Filing 18 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. ( #1 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (London, Michael)
October 22, 2020	Filing 17 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544)( 56 in MDL No. 2973) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/22/2020 (TF). REMOVED DUPLICATE PARTIES. ADDED MDL LINK.
October 22, 2020	Filing 16 HEARING ORDER re: pldg. ( #1 in MDL No. 2973) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 12/3/2020 in Washington, DC. Notices of Presentation or Waiver of Oral Argument due on or before 11/9/2020.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/22/2020. Associated Cases: MDL No. 2973 et al. (RH)
October 15, 2020	Filing 15 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES.
October 15, 2020	Filing 14 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendant JANSSEN PHARMACEUTICALS, INC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES.
October 13, 2020	Filing 13 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544) Filed by Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/13/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 12 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for ORTHO -MCNEIL PHARMACEUTICAL, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent No Parent Corp. for JOHNSON & JOHNSON. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Centocor Research & Development, Inc. for JANSSEN RESEARCH & DEVELOPMENT LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 9 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, FLS/1:20-cv-23144, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12605, NJ/3:20-cv-12608 (McIntosh, Thomas) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for JANSSEN PHARMACEUTICALS INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 7 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Thomas G McIntosh on behalf of Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent OMJ PR Holdings for JANSSEN ORTHO LLC. Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020	Filing 5 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants ALZA CORPORATION, CENTOCOR RESEARCH & DEVELOPMENT, INC., JANSSEN ORTHO LLC, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC, ORTHO-MCNEIL PHARMACEUTICALS, INC., JOHNSON & JOHNSON, BAYER CORPORATION, BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., AND BAYER US LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
September 25, 2020	Filing 4 RESPONSE IN SUPPORT -- (re: pldg. ( #4 in MDL No. 2973), ( 1 in MDL No. 2973) ) Filed by Plaintiffs LYNN BREWER, #et al.WILLIAM BREWER, CARLIE ANTHONY, REBECCA ANTHONY, EDWARD HULL, VALERIE HULL, DEBORAH EDWARDS, LINDA HOLMBERG, ROY DANIEL HOLMBERG, BARBARA MAYOU, KEITH MAYOU, DAVID MCCALL, SHERYL MCCALL, HARRIET COMSTOCK, CAROL HARDY, ROGER HARDY #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Exhibit 1 - Sheryl McCall - 3:20-cv-08074, #3 Exhibit 2 - Valerie Hull - 2:20-cv-07079, #4 Proof of Service) Associated Cases: MDL No. 2973, NJ/2:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-11440, NJ/3:20-cv-12605, NJ/3:20-cv-12608 (Shkolnik, Hunter) Modified on 9/25/2020 (TF). REMOVED DUPLICATE ATTACHMENTS.
September 25, 2020	Filing 3 NOTICE OF APPEARANCE re: pldg.( #4 in MDL No. 2973), ( 1 in MDL No. 2973) Filed by Hunter J. Shkolnik on behalf of Plaintiffs LYNN BREWER, #et al.WILLIAM BREWER, LINDA HOLMBERG, ROY DANIEL HOLMBERG, BARBARA MAYOU, KEITH MAYOU, DAVID MCCALL, SHERYL MCCALL, CAROL HARDY, ROGER HARDY, CARLIE ANTHONY, REBECCA ANTHONY, EDWARD HULL, VALERIE HULL, DEBORAH EDWARDS, HARRIET COMSTOCK #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, NJ/2:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-11440, NJ/3:20-cv-12605, NJ/3:20-cv-12608 (Shkolnik, Hunter) Modified on 9/25/2020 (TF). REMOVED DUPLICATE ATTACHMENTS.
September 24, 2020	Filing 2 *TEXT ONLY NOTICE*NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 2973) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 10/8/2020. Corporate Disclosure Statements due on or before 10/8/2020. Responses due on or before 10/15/2020. Reply, if any, due on or before 10/22/2020. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 9/24/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH)
September 24, 2020	Filing 1 MDL Number 2973 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 135) Associated Cases: Pending No. 135, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: HARDY et al v. JANSSEN PHARMACEUTICALS, INC. et al
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Web	[ Unicourt \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: HARDY
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: ROGER HARDY
Represented By:	Hunter J. Shkolnik
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: CAROL HARDY
Represented By:	Hunter J. Shkolnik
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JANSSEN PHARMACEUTICALS, INC
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JANSSEN RESEARCH & DEVELOPMENT LLC
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Kristen R. Fournier
Represented By:	Janssen Research & Development, LLC
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JANSSEN PHARMACEUTICA INC
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Janssen Pharamaceuticals, Inc.
Represented By:	Kristen R. Fournier
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: ORTHO-MCNEIL PHARMACEUTICALS, LLC
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	ORTHO-MCNEIL PHARMACEUTICALS, LLC
Represented By:	Kristen R. Fournier
Represented By:	Michael Charles Zogby
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JANSSEN ORTHO, LLC
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Janssen Ortho, LLC
Represented By:	Kristen R. Fournier
Represented By:	Michael Charles Zogby
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Represented By:	Teva Branded Pharmaceutical Products R&D, Inc.
Represented By:	Thomas G McIntosh
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC.
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Janssen Pharamaceuticals, Inc.
Represented By:	Kristen R. Fournier
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Kristen R. Fournier
Represented By:	Janssen Research & Development, LLC
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: JOHNSON & JOHNSON
Represented By:	Johnson & Johnson
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Kristen R. Fournier
Represented By:	Michael Charles Zogby
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: ABC CORPORATION 1-20
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Janssen Pharmaceuticals Inc.
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Kristen R. Fournier
Represented By:	Janssen Pharamaceuticals, Inc.
Represented By:	Michael Charles Zogby
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Janssen Research and Developement, LLC
Represented By:	Kristen R. Fournier
Represented By:	Tracie J Renfroe
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Michael Charles Zogby
Represented By:	Janssen Research & Development, LLC
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC.
Represented By:	Michael Charles Zogby
Represented By:	Tracie J Renfroe
Represented By:	Janssen Pharamaceuticals, Inc.
Represented By:	Kristen R. Fournier
Represented By:	Robert Bruce Hurley, Jr
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Represented By:	Kristen R. Fournier
Represented By:	Tracie J Renfroe
Represented By:	Michael Charles Zogby
Represented By:	Robert Bruce Hurley, Jr
Represented By:	Janssen Research & Development, LLC
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC
Represented By:	Teva Branded Pharmaceutical Products R&D, Inc.
Represented By:	Thomas G McIntosh
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?